Immunological Aspects of Trichomonas vaginalis Infection in Women Attending Maternity Teaching Hospital and Some Public Health Centers in Erbil Governorate, Northern Iraq

  • Avreen Salahaddin Nouraddin Public Health Laboratory, Erbil Health Directorate, Erbil, Iraq
  • Hadi Mahdi Alsakee Department of Biology, Cihan University-Erbil, Kurdistan Region, Iraq http://orcid.org/0000-0002-3387-8106
Keywords: Anticardiolipin antibodies, antiphospholipid antibodies, C-reactive protein, cytokines, IL-10

Abstract

Trichomonas vaginalis infection is one of the sexually transmitted diseases. It is a health problem all over the world, including Iraq. It has also been associated with adverse outcomes of pregnancy and increased risk of HIV. Trichomoniasis typically elicits aggressive local cellular immune responses with inflammation of the vaginal epithelium and exocervix in women and urethra in men. The present study was aimed to assess serum level of interferon gamma (IFN-γ), Interleukin 10 (IL-10), C-reactive protein, antiphospholipid, anticardiolipin antibodies with eosinophil count as well. Four hundred and forty women with ages ranging between 16 and 60 years old (average of 34.2 years) who attended Maternity Teaching Hospital and a number of public health centers in Erbil Governorate were screened for trichomoniasis by direct wet mount preparation and culture technique. Serum IFN-γ, IL-10, antiphospholipid, and anticardiolipin were assessed by enzyme-linked immunosorbent assay. C-reactive protein (CRP) and eosinophil count were assessed by I CROMA and Coulter, respectively. The results revealed that IL-10 level (96.46 ± 1.97 pg/ml vs. 91.86 ± 1.48 pg/ml), eosinophil count (0.1 ± 0.07 × 10³/μL vs. 0.1 ± 0.01 × 10³/μL), and CRP concentration (2.55 ± 0.74 mg/l vs. 2.27 ± 0.37 mg/l) were non-significantly (P > 0.05) changed in infected women in comparison with negative control group. However, serum IFN-γ level (484.83 ± 38.35 pg/ml vs. 372.15 ± 9.49 pg/ml) was significantly (P < 0.05) elevated in infected women in comparison to the control group. The results also revealed significant increase (P < 0.05) of antiphospholipid immunoglobulin G (IgG) antibodies (4.75 ± 0.3 U/ml vs. 3.79 ± 0.11 U/ml) in the sera of infected women, but antiphospholipid immunoglobulin M (IgM), anticardiolipin IgG, and anticardiolipin IgM antibodies were non-significantly altered in response to T. vaginalis infection.

Downloads

Download data is not yet available.

References

F. Xueqiang, Z. Yingzhi, Y. Yanfang, D. Yutao and L. Huiqing.“Prevalence and risk factors of trichomoniasis, bacterial vaginosis, and candidiasis for married women of childbearing age in Rural Shandong”. Japanese Journal of Infectious Diseases, vol. 60, no. 5, pp. 257-261, 2007.

V. J. Johnston and D. C. Mabey. “Global epidemiology and control of Trichomonas vaginalis”. Current Opinion in Infectious Diseases, vol. 21, no. 1, pp. 56-64, 2008.

D. N. Poole and R. S. Mcclelland.“Global epidemiology of Trichomonas vaginalis”. Sexually Transmitted Infections, vol. 89, pp. 418-422, 2013.

A. E. Miranda, V. M. Pinto and C. A. Gaydos. “Trichomonas vaginalis infection among young pregnant women in Brazil”. The Brazilian Journal of Infectious Diseases, vol. 18, no. 6, pp. 669-671, 2014.

C. Nardis, L. Mosca and P. Mastromarino. “Vaginal microbiota and viral sexually transmitted diseases.” Ann Lg, vol. 25, no. 5, pp. 443-456, 2013.

O. O. Asemota. “Trichomoniasis in Nigeria : A review”. Biomedical Research, vol. 29, no. 12, pp. 2532-2539, 2018.

K. Bouchemal, C. Bories and P. M. Loiseau. “Strategies for prevention and treatment of Trichomonas vaginalis infections”. Clinical Microbiology Reviews, vol. 30, no. 3, pp. 811-825, 2017.

J. J. Lee, H. S. Moon, T. Y. Lee, H. S. Hwang, M. Ahn and J. Ryu. “PCR for diagnosis of male Trichomonas vaginalis infection with chronic prostatitis and urethritis”. The Korean Journal of Parasitology, vol. 50, no. 2, pp. 157-159, 2012.

R. S. Mcclelland, L. Sangare, W. M. Hassan, L. Lavreys, K. Mandaliya, J. Kiarie, J. Ndinya-achola, W. Jaoko and J. M. Baeten. “Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition”. The Journal of Infectious Diseases, vol. 195, no.5, pp. 2-6, 2007.

O. E. Chinyere, I. I. Romanus, O. N. Collins, N. Okoro and O. E. Anthonia. “Trichomonas vaginalis associated with adverse pregnancy outcomes : Implications for maternal health care delivery system in South Eastern Nigeria”. Biomedical Research, vol. 2, no. 4, pp. 568-574, 2012.

J. H. Fowke, X. Han, J. F. Alderete, K. A. Moses, L. B. Signorello and W. J. Blot. “A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men.” BMC Research Notes, vol. 9, p. 224, 2016.

F. Mercer, F. G. I. Diala, Y. Chen, B. M. Molgora, H. Ng and P. J. Johnson. “Leukocyte lysis and cytokine induction by the human sexually transmitted parasite Trichomonas vaginalis”. PLoS Neglected Tropical Diseases, vol. 10, pp. 1-19, 2016.

H. I. Khalil, A. H. Al-kuraishi, U. A. M. Ai-naimi and A. Suhai. “Trichomoniasis Vaginalis in women attending family planning unit in AL-Liqa a Hospital. Iraqi Journal of Science, vol. 53, no. 2, pp. 747-754, 2012.

A. S. Nouraddin and H. M. Alsakee. “Prevalence of Trichomonas vaginalis infection among women in erbil governorate, Northern Iraq: An epidemiological approach”. European Scientific Journal, vol. 11, no. 24, pp. 243-255, 2015.

M. A. Z. Merdaw, H. S. Khadim, F. Alriyahee, N. M. T. Al-Bashier and L. H. Al-Taie. “Genetic variation of Trichomonas vaginalis isolates from Iraqi Women : Association with fertility and cervical abnormalities”. Journal of University of Babylon for Pure and Applied Sciences. vol. 26, no. 7, pp. 321-338, 2018.

N. R. Sproston and J. J. Ashworth. “Role of C-reactive protein at sites of inflammation and infection”. Frontiers in Immunology, vol. 9, pp. 1-11, 2018.

M. J. Shaker and R. A. Hussein. “Immunological study of women infected with Trichomonas vaginalis parasite in Baghdad city”. International Journal of Science and Research, vol. 3, no. 9, pp. 1145-1148, 2014.

D. González-fernández, C. Pons, D. Rueda, O. T. Sinisterra, E. Murillo, M. E. Scott and K. G. Koski. “C-reactive protein is differentially modulated by co-existing infections, vitamin deficiencies and maternal factors in pregnant and lactating indigenous Panamanian women”. Infectious Diseases of Poverty, vol. 6, p. 94, 2017.

A. F. B. Al-Gazali, K. A. A. Maysoon and A. A. A. Haqi. “Study of blood parameter in women infected with Trichomonas vaginalis parasite”. Journal of Kerbala University, vol. 11, no. 4, pp. 223-227, 2013.

L. E. Layland, A. Hoerauf and P. H. Marc. “Helminths and their implication in sepsis a new branch of their immunomodulatory behaviour” ? Pathogens and Disease, vol. 69, no. 2. pp. 127-141, 2013.

M. Shaio, P. Lin, J. Liu and K. D. Yang. “Generation of interleukin-8 from human monocytes in response to Trichomonas vaginalis stimulation”. Infection and Immunity, vol. 63, no. 10, pp. 3864-3870, 1995.

H. Song, Y. Lim, S. Moon, M. Ahn and J. Ryu. “Delayed human neutrophil apoptosis by Trichomonas vaginalis lysate”. The Korean Journal of Parasitology, vol. 48, no. 1, pp. 1-7, 2010.

R. N. F. Bibhuti, N. Singh, G. R. Hayes, J. J. Lucas, U. Sommer, N. Viseux, E. Mirgorodskaya, R. T. Trifonova, R. R. Sassi and C. E. Costello. “Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function,” Glycoconjugate Journal, vol. 26, no. 1, pp. 3-17, 2009.

R. C. Vilela and M. Benchimol. “IL-10 release by bovine epithelial cells cultured with Trichomonas vaginalis and Tritrichomonas foetus”. Memórias do Instituto Oswaldo Cruz, vol. 108, no. 1, pp. 110-112, 2013.

E. Ortona, P. Margutti, F. Delunardo, S. Vaccari, R. Riganò, E. Profumo, B. Buttari, A. Teggi and A. Siracusano. “Molecular and immunological characterization of the C-terminal region of a new Echinococcus granulosus heat shock protein 70”. Parasite Immunology, vol. 25, no. 3, pp. 119-126, 2003.

N. Malla, M. Yadav and I. Gupta. “Kinetics of serum and local cytokine profile in experimental intravaginal trichomoniasis induced with Trichomonas vaginalis isolates from symptomatic and asymptomatic women”. Parasite Immunology, vol. 29, no. 2, pp. 101-105, 2007.

R. N. Fichorova, R. T. Trifonova, R. O. Gilbert, C. E. Costello, G. R. Hayes, J. J. Lucas and B. N. Singh. “Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Parasite Immunology, vol. 74, no. 10, pp. 5773-5779, 2006.

H. M. A. Al-sakee. “Autoantibodies in human cystic echinococcosis.” Tikrit Medical Journal, vol. 17, no. 1, pp. 53-63, 2011.

W. Dowhan. “Understanding phospholipid function: Why are there so many lipids”? Journal of Biological Chemistry, vol. 292, no. 26, pp. 10755-10766, 2017.

F. A. F. Di Prima, O. Valenti, E. Hyseni, E. Giorgio, M. Faraci, E. Renda, R. De Domenico and S. Monte. “Antiphospholipid Syndrome during pregnancy: The state of the art”. Journal of Prenatal Medicine, vol. 5, no. 2, pp. 41-53, 2011.

Published
2019-06-30
How to Cite
1.
Nouraddin A, Alsakee H. Immunological Aspects of Trichomonas vaginalis Infection in Women Attending Maternity Teaching Hospital and Some Public Health Centers in Erbil Governorate, Northern Iraq. cuesj [Internet]. 30Jun.2019 [cited 27Jan.2022];3(1):56-0. Available from: https://journals.cihanuniversity.edu.iq/index.php/cuesj/article/view/91
Section
Research Article

Most read articles by the same author(s)